{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T18:25:34Z","timestamp":1767983134847,"version":"3.49.0"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2013,10,30]],"date-time":"2013-10-30T00:00:00Z","timestamp":1383091200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Lung"],"published-print":{"date-parts":[[2014,2]]},"DOI":"10.1007\/s00408-013-9526-9","type":"journal-article","created":{"date-parts":[[2013,10,29]],"date-time":"2013-10-29T04:09:12Z","timestamp":1383019752000},"page":"197-203","source":"Crossref","is-referenced-by-count":30,"title":["Serum Biomarkers in Patients with Mesothelioma and Pleural Plaques and Healthy Subjects Exposed to Naturally Occurring Asbestos"],"prefix":"10.1007","volume":"192","author":[{"given":"Mehmet","family":"Bayram","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Isa","family":"Dongel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ali","family":"Akba\u015f","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"\u0130smail","family":"Benli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Muhammed Emin","family":"Akkoyunlu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nur Dilek","family":"Bakan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2013,10,30]]},"reference":[{"key":"9526_CR1","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/S0022-5223(99)70469-1","volume":"117","author":"DJ Sugarbaker","year":"1999","unstructured":"Sugarbaker DJ, Flores RM, Jaklitsch MT et al (1999) Resection margins, extrapleural nodal status, and cell type determine postoperative long-term survival in trimodality therapy of malignant pleural mesothelioma: results in 183 patients. J Thorac Cardiovasc Surg 117:54\u201363 discussion 63\u201355","journal-title":"J Thorac Cardiovasc Surg"},{"key":"9526_CR2","doi-asserted-by":"crossref","unstructured":"Zellos L, Christiani DC (2004) Epidemiology, biologic behavior, and natural history of mesothelioma. Thorac Surg Clin 14:469-477, viii","DOI":"10.1016\/j.thorsurg.2004.06.011"},{"key":"9526_CR3","doi-asserted-by":"crossref","first-page":"2636","DOI":"10.1200\/JCO.2003.11.136","volume":"21","author":"NJ Vogelzang","year":"2003","unstructured":"Vogelzang NJ, Rusthoven JJ, Symanowski J et al (2003) Phase III study of pemetrexed in combination with cisplatin versus cisplatin alone in patients with malignant pleural mesothelioma. J Clin Oncol 21:2636\u20132644","journal-title":"J Clin Oncol"},{"key":"9526_CR4","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1183\/09031936.00226111","volume":"41","author":"I Pantazopoulos","year":"2013","unstructured":"Pantazopoulos I, Boura P, Xanthos T et al (2013) Effectiveness of mesothelin family proteins and osteopontin for malignant mesothelioma. Eur Respir J 41:706\u2013715","journal-title":"Eur Respir J"},{"key":"9526_CR5","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1158\/1078-0432.CCR-05-1477","volume":"12","author":"R Hassan","year":"2006","unstructured":"Hassan R, Remaley AT, Sampson ML et al (2006) Detection and quantitation of serum mesothelin, a tumor marker for patients with mesothelioma and ovarian cancer. Clin Cancer Res 12:447\u2013453","journal-title":"Clin Cancer Res"},{"key":"9526_CR6","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1373\/clinchem.2006.079327","volume":"53","author":"HL Beyer","year":"2007","unstructured":"Beyer HL, Geschwindt RD, Glover CL et al (2007) MESOMARK: a potential test for malignant pleural mesothelioma. Clin Chem 53:666\u2013672","journal-title":"Clin Chem"},{"key":"9526_CR7","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.1016\/S0140-6736(03)14794-0","volume":"362","author":"BW Robinson","year":"2003","unstructured":"Robinson BW, Creaney J, Lake R et al (2003) Mesothelin-family proteins and diagnosis of mesothelioma. Lancet 362:1612\u20131616","journal-title":"Lancet"},{"key":"9526_CR8","first-page":"4060","volume":"7","author":"NS Fedarko","year":"2001","unstructured":"Fedarko NS, Jain A, Karadag A et al (2001) Elevated serum bone sialoprotein and osteopontin in colon, breast, prostate, and lung cancer. Clin Cancer Res 7:4060\u20134066","journal-title":"Clin Cancer Res"},{"key":"9526_CR9","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1056\/NEJMoa051185","volume":"353","author":"HI Pass","year":"2005","unstructured":"Pass HI, Lott D, Lonardo F et al (2005) Asbestos exposure, pleural mesothelioma, and serum osteopontin levels. N Engl J Med 353:1564\u20131573","journal-title":"N Engl J Med"},{"key":"9526_CR10","doi-asserted-by":"crossref","first-page":"2928","DOI":"10.1158\/1078-0432.CCR-06-2144","volume":"13","author":"BD Grigoriu","year":"2007","unstructured":"Grigoriu BD, Scherpereel A, Devos P et al (2007) Utility of osteopontin and serum mesothelin in malignant pleural mesothelioma diagnosis and prognosis assessment. Clin Cancer Res 13:2928\u20132935","journal-title":"Clin Cancer Res"},{"key":"9526_CR11","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1158\/1078-0432.CCR-08-0360","volume":"15","author":"EK Park","year":"2009","unstructured":"Park EK, Thomas PS, Johnson AR et al (2009) Osteopontin levels in an asbestos-exposed population. Clin Cancer Res 15:1362\u20131366","journal-title":"Clin Cancer Res"},{"key":"9526_CR12","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1097\/MCP.0b013e328354acfe","volume":"18","author":"R Myers","year":"2012","unstructured":"Myers R (2012) Asbestos-related pleural disease. Curr Opin Pulm Med 18:377\u2013381","journal-title":"Curr Opin Pulm Med"},{"key":"9526_CR13","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1378\/chest.11-2727","volume":"143","author":"M Bayram","year":"2013","unstructured":"Bayram M, Dongel I, Bakan ND et al (2013) High risk of malignant mesothelioma and pleural plaques in subjects born close to ophiolites. Chest 143:164\u2013171","journal-title":"Chest"},{"key":"9526_CR14","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1289\/ehp.1002862","volume":"119","author":"F Baumann","year":"2011","unstructured":"Baumann F, Maurizot P, Mangeas M et al (2011) Pleural mesothelioma in New Caledonia: associations with environmental risk factors. Environ Health Perspect 119:695\u2013700","journal-title":"Environ Health Perspect"},{"key":"9526_CR15","first-page":"339","volume":"10","author":"F Rey","year":"1993","unstructured":"Rey F, Viallat JR, Boutin C et al (1993) Environmental mesotheliomas in northeast Corsica. Rev Mal Respir 10:339\u2013345","journal-title":"Rev Mal Respir"},{"key":"9526_CR16","unstructured":"McConnochie K, Simonato L, Mavrides P et al (1989) Mesothelioma in Cyprus. IARC Sci Publ 411\u2013419"},{"key":"9526_CR17","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1378\/chest.126.2.617","volume":"126","author":"C Manda-Stachouli","year":"2004","unstructured":"Manda-Stachouli C, Dalavanga Y, Daskalopoulos G et al (2004) Decreasing prevalence of pleural calcifications among Metsovites with nonoccupational asbestos exposure. Chest 126:617\u2013621","journal-title":"Chest"},{"key":"9526_CR18","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1289\/ehp.01109915","volume":"109","author":"C Magnani","year":"2001","unstructured":"Magnani C, Dalmasso P, Biggeri A et al (2001) Increased risk of malignant mesothelioma of the pleura after residential or domestic exposure to asbestos: a case-control study in Casale Monferrato, Italy. Environ Health Perspect 109:915\u2013919","journal-title":"Environ Health Perspect"},{"key":"9526_CR19","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1164\/rccm.200412-1731OC","volume":"172","author":"XL Pan","year":"2005","unstructured":"Pan XL, Day HW, Wang W et al (2005) Residential proximity to naturally occurring asbestos and mesothelioma risk in California. Am J Respir Crit Care Med 172:1019\u20131025","journal-title":"Am J Respir Crit Care Med"},{"key":"9526_CR20","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1097\/00063198-200007000-00020","volume":"6","author":"MR Orenstein","year":"2000","unstructured":"Orenstein MR, Schenker MB (2000) Environmental asbestos exposure and mesothelioma. Curr Opin Pulm Med 6:371\u2013377","journal-title":"Curr Opin Pulm Med"},{"key":"9526_CR21","first-page":"838","volume":"45","author":"YI Baris","year":"1988","unstructured":"Baris YI, Bilir N, Artvinli M et al (1988) An epidemiological study in an Anatolian village environmentally exposed to tremolite asbestos. Br J Ind Med 45:838\u2013840","journal-title":"Br J Ind Med"},{"key":"9526_CR22","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1080\/10937404.2011.556045","volume":"14","author":"BW Case","year":"2011","unstructured":"Case BW, Abraham JL, Meeker G et al (2011) Applying definitions of \u201casbestos\u201d to environmental and \u201clow-dose\u201d exposure levels and health effects, particularly malignant mesothelioma. J Toxicol Environ Health B Crit Rev 14:3\u201339","journal-title":"J Toxicol Environ Health B Crit Rev"},{"key":"9526_CR23","first-page":"162","volume":"6","author":"C Bianchi","year":"1997","unstructured":"Bianchi C, Giarelli L, Grandi G et al (1997) Latency periods in asbestos-related mesothelioma of the pleura. Eur J Cancer Prev 6:162\u2013166","journal-title":"Eur J Cancer Prev"},{"key":"9526_CR24","volume-title":"The assessment of the malignant mesothelioma cases and environmental asbestos exposure in Sivas province","author":"S Berk","year":"2013","unstructured":"Berk S, Yalcin H, Dogan OT et al (2013) The assessment of the malignant mesothelioma cases and environmental asbestos exposure in Sivas province. Environ Geochem Health, Turkey"},{"key":"9526_CR25","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.1164\/ajrccm.158.6.9712119","volume":"158","author":"P Dumortier","year":"1998","unstructured":"Dumortier P, Coplu L, de Maertelaer V et al (1998) Assessment of environmental asbestos exposure in Turkey by bronchoalveolar lavage. Am J Respir Crit Care Med 158:1815\u20131824","journal-title":"Am J Respir Crit Care Med"},{"key":"9526_CR26","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1016\/j.rmed.2013.03.006","volume":"107","author":"I Dongel","year":"2013","unstructured":"Dongel I, Bayram M, Bakan ND et al (2013) Is living close to ophiolites related to asbestos related diseases? Cross-sectional study. Respir Med 107:870\u2013874","journal-title":"Respir Med"},{"key":"9526_CR27","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1378\/chest.07-0013","volume":"132","author":"J Creaney","year":"2007","unstructured":"Creaney J, van Bruggen I, Hof M et al (2007) Combined CA125 and mesothelin levels for the diagnosis of malignant mesothelioma. Chest 132:1239\u20131246","journal-title":"Chest"},{"key":"9526_CR28","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1158\/1055-9965.EPI-08-0422","volume":"18","author":"JA Rodriguez Portal","year":"2009","unstructured":"Rodriguez Portal JA, Rodriguez Becerra E, Rodriguez Rodriguez D et al (2009) Serum levels of soluble mesothelin-related peptides in malignant and nonmalignant asbestos-related pleural disease: relation with past asbestos exposure. Cancer Epidemiol Biomarkers Prev 18:646\u2013650","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"9526_CR29","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1164\/rccm.200511-1789OC","volume":"173","author":"A Scherpereel","year":"2006","unstructured":"Scherpereel A, Grigoriu B, Conti M et al (2006) Soluble mesothelin-related peptides in the diagnosis of malignant pleural mesothelioma. Am J Respir Crit Care Med 173:1155\u20131160","journal-title":"Am J Respir Crit Care Med"},{"key":"9526_CR30","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1097\/JTO.0b013e31821e1c08","volume":"6","author":"A Cristaudo","year":"2011","unstructured":"Cristaudo A, Bonotti A, Simonini S et al (2011) Combined serum mesothelin and plasma osteopontin measurements in malignant pleural mesothelioma. J Thorac Oncol 6:1587\u20131593","journal-title":"J Thorac Oncol"},{"key":"9526_CR31","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1007\/s00204-010-0580-2","volume":"85","author":"M Gube","year":"2011","unstructured":"Gube M, Taeger D, Weber DG et al (2011) Performance of biomarkers SMRP, CA125, and CYFRA 21-1 as potential tumor markers for malignant mesothelioma and lung cancer in a cohort of workers formerly exposed to asbestos. Arch Toxicol 85:185\u2013192","journal-title":"Arch Toxicol"},{"key":"9526_CR32","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1164\/rccm.200907-1020OC","volume":"181","author":"K Hollevoet","year":"2010","unstructured":"Hollevoet K, Nackaerts K, Thimpont J et al (2010) Diagnostic performance of soluble mesothelin and megakaryocyte potentiating factor in mesothelioma. Am J Respir Crit Care Med 181:620\u2013625","journal-title":"Am J Respir Crit Care Med"},{"key":"9526_CR33","first-page":"364","volume":"5","author":"FJ Brims","year":"2013","unstructured":"Brims FJ, Lee YC, Creaney J (2013) The continual search for ideal biomarkers for mesothelioma: the hurdles. J Thorac Dis 5:364\u2013366","journal-title":"J Thorac Dis"},{"key":"9526_CR34","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1164\/rccm.200811-1729OC","volume":"180","author":"HE Davies","year":"2009","unstructured":"Davies HE, Sadler RS, Bielsa S et al (2009) Clinical impact and reliability of pleural fluid mesothelin in undiagnosed pleural effusions. Am J Respir Crit Care Med 180:437\u2013444","journal-title":"Am J Respir Crit Care Med"},{"key":"9526_CR35","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1158\/1055-9965.EPI-07-0607","volume":"17","author":"M Amati","year":"2008","unstructured":"Amati M, Tomasetti M, Scartozzi M et al (2008) Profiling tumor-associated markers for early detection of malignant mesothelioma: an epidemiologic study. Cancer Epidemiol Biomarkers Prev 17:163\u2013170","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"9526_CR36","first-page":"1427","volume":"31","author":"K Shiomi","year":"2011","unstructured":"Shiomi K, Shiomi S, Ishinaga Y et al (2011) Impact of renal failure on the tumor markers of mesothelioma, N-ERC\/mesothelin and osteopontin. Anticancer Res 31:1427\u20131430","journal-title":"Anticancer Res"},{"key":"9526_CR37","doi-asserted-by":"crossref","first-page":"2480","DOI":"10.1158\/1055-9965.EPI-08-0150","volume":"17","author":"KA Lowe","year":"2008","unstructured":"Lowe KA, Shah C, Wallace E et al (2008) Effects of personal characteristics on serum CA125, mesothelin, and HE4 levels in healthy postmenopausal women at high-risk for ovarian cancer. Cancer Epidemiol Biomarkers Prev 17:2480\u20132487","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"9526_CR38","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1373\/clinchem.2008.121913","volume":"55","author":"K Hollevoet","year":"2009","unstructured":"Hollevoet K, Bernard D, De Geeter F et al (2009) Glomerular filtration rate is a confounder for the measurement of soluble mesothelin in serum. Clin Chem 55:1431\u20131433","journal-title":"Clin Chem"},{"key":"9526_CR39","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/j.cyto.2012.12.028","volume":"61","author":"K Samitas","year":"2013","unstructured":"Samitas K, Zervas E, Xanthou G et al (2013) Osteopontin is increased in the bronchoalveolar lavage fluid and bronchial tissue of smoking asthmatics. Cytokine 61:713\u2013715","journal-title":"Cytokine"},{"key":"9526_CR40","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.lungcan.2011.02.007","volume":"74","author":"J Creaney","year":"2011","unstructured":"Creaney J, Yeoman D, Musk AW et al (2011) Plasma versus serum levels of osteopontin and mesothelin in patients with malignant mesothelioma\u2013which is best? Lung Cancer 74:55\u201360","journal-title":"Lung Cancer"}],"container-title":["Lung"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00408-013-9526-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00408-013-9526-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00408-013-9526-9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,28]],"date-time":"2019-05-28T18:37:57Z","timestamp":1559068677000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00408-013-9526-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,10,30]]},"references-count":40,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,2]]}},"alternative-id":["9526"],"URL":"https:\/\/doi.org\/10.1007\/s00408-013-9526-9","relation":{},"ISSN":["0341-2040","1432-1750"],"issn-type":[{"value":"0341-2040","type":"print"},{"value":"1432-1750","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,10,30]]}}}